6 invalidation requests to watch: Chinese companies challenge global pharmaceutical giants’ patents
Patent linkage was introduced into the 4th amendment to the Patent Law of the People’s Republic of China effective June 1, 2021. Unprecedentedly, Article 76 of the Patent Law provides a "dual-track" early resolution mechanism for resolving drug patent disputes during the marketing approval